UroGen Pharma Ltd. Quarterly Return On Equity in % from Q4 2017 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
UroGen Pharma Ltd. quarterly/annual Return On Equity history and growth rate from Q4 2017 to Q2 2024.
  • UroGen Pharma Ltd. Return On Equity for the quarter ending June 30, 2024 was 388 %, a 263% increase year-over-year.
  • UroGen Pharma Ltd. annual Return On Equity for 2023 was 113 %, a 45.8% decline from 2022.
  • UroGen Pharma Ltd. annual Return On Equity for 2022 was 208 %.
  • UroGen Pharma Ltd. annual Return On Equity for 2021 was -257 %, a 155% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 388 +281 +263% Apr 1, 2024 Jun 30, 2024
Q1 2024 146 +2.06 +1.43% Jan 1, 2024 Mar 31, 2024
Q4 2023 113 -95.6 -45.8% Oct 1, 2023 Dec 31, 2023
Q3 2023 109 -279 -71.9% Jul 1, 2023 Sep 30, 2023
Q2 2023 107 -2.42K -95.8% Apr 1, 2023 Jun 30, 2023
Q1 2023 144 +716 Jan 1, 2023 Mar 31, 2023
Q4 2022 208 +465 Oct 1, 2022 Dec 31, 2022
Q3 2022 388 +561 Jul 1, 2022 Sep 30, 2022
Q2 2022 2.52K +2.65K Apr 1, 2022 Jun 30, 2022
Q1 2022 -572 -466 -435% Jan 1, 2022 Mar 31, 2022
Q4 2021 -257 -156 -155% Oct 1, 2021 Dec 31, 2021
Q3 2021 -173 -81 -87.9% Jul 1, 2021 Sep 30, 2021
Q2 2021 -128 -51.4 -67.4% Apr 1, 2021 Jun 30, 2021
Q1 2021 -107 -43.6 -68.7% Jan 1, 2021 Mar 31, 2021
Q4 2020 -101 -51.6 -105% Oct 1, 2020 Dec 31, 2020
Q3 2020 -92.2 -45.2 -96.3% Jul 1, 2020 Sep 30, 2020
Q2 2020 -76.2 -22.6 -42.2% Apr 1, 2020 Jun 30, 2020
Q1 2020 -63.4 -2.17 -3.54% Jan 1, 2020 Mar 31, 2020
Q4 2019 -49.2 +21 +30% Oct 1, 2019 Dec 31, 2019
Q3 2019 -47 +13.6 +22.5% Jul 1, 2019 Sep 30, 2019
Q2 2019 -53.6 -9.86 -22.5% Apr 1, 2019 Jun 30, 2019
Q1 2019 -61.2 -26.3 -75.1% Jan 1, 2019 Mar 31, 2019
Q4 2018 -70.2 -35.7 -104% Oct 1, 2018 Dec 31, 2018
Q3 2018 -60.6 Jul 1, 2018 Sep 30, 2018
Q2 2018 -43.7 Apr 1, 2018 Jun 30, 2018
Q1 2018 -35 Jan 1, 2018 Mar 31, 2018
Q4 2017 -34.5 Oct 1, 2017 Dec 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.